688273 Nanjing Medlander Medical Technology

Has Nanjing Medlander Medical Technology Co.,Ltd.'s (SHSE:688273) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Most readers would already be aware that Nanjing Medlander Medical TechnologyLtd's (SHSE:688273) stock increased significantly by 33% over the past three months. Given that stock prices are usually

03-23 08:42

Mailand (688273.SH) granted 3.09 million restricted shares at a price of 21.16 yuan/share

According to the Zhitong Finance App, McLander (688273.SH) announced that the restricted stock grant conditions stipulated in the “2023 Restricted Stock Incentive Plan (Draft)” have been fulfilled. The company determined that the first restricted stock grant date was March 14, 2023, and granted 3.09 million restricted shares to 96 incentive recipients who met the grant conditions at a grant price of 21.16 yuan/share, including 620 million first-class restricted stocks and 2.47 million second-class restricted stocks.

03-14 20:58

Mailand (688273.SH): The company's reproductive anti-aging series products are also suitable for medical and aesthetic customer groups

Gronghui, March 6 | When surveyed by the agency on February 27, 2023, McLander (688273.SH) said that the company's reproductive anti-aging products can be expanded horizontally. Apart from traditional medical institutions, they are also suitable for medical and aesthetic customer groups.

03-06 21:55

McLander (688273.SH): A new automated uterine recovery device launched in the second half of 2022 helps reproductive rehabilitation lines achieve exponential growth

Glonghui, March 6, 丨When surveyed by the agency on February 27, 2023, McLander (688273.SH) said that reproductive anti-aging is the second strategic product line proposed by the company after pelvic floor rehabilitation. Based on industry market space, national policy orientation, and the company's reserved technical advantages, the company has high expectations for the reproductive rehabilitation line. The new automatic uterine recovery device launched in the second half of 2022 helped the reproductive rehabilitation line grow exponentially. In 2023, the company will set up professional sales teams, product managers, and medical managers to increase investment in the reproductive rehabilitation sector. The reproductive rehabilitation markets that the company targets include

03-06 21:50

Mailand (688273.SH): Currently, reproductive rehabilitation related products have a first-mover advantage on the market

Gronghui, March 6, 丨When surveyed by the agency on February 27, 2023, McLander (688273.SH) said that in the pelvic floor rehabilitation sector, ① the company invented a disposable screening method and a disposable vaginal electrode, which solved the pain points of high consumables costs and met the needs of large-scale population screening; ② invented intelligent algorithms to target different diseases and groups of people, and solved the pain points of complex operation, learning curves and high costs for doctors and patients, which satisfied simplified operation, reduced learning costs, and reduced doctor-patient communication costs , increasing the need for compliance;

03-06 21:50

Changes in A-shares | Mailand rose 9% to push for equity incentive plans and was favored by brokerage firms

Glonghui, Feb. 27 | Mailand (688273.SH) rushed back down, surging 14.6% during the intraday period. It is now reported at 45.48 yuan, an increase of 9%, with a total market value of 4,548 billion yuan. The company plans to grant 3.3 million restricted shares to incentive targets. According to Huaan Securities, the equity incentive plan points the direction for the company's medium- to long-term growth in 2023-2026. Based on the friendly policy environment of the company's industry, the synergistic effect of the company's product portfolio is strong, the company's medium- to long-term equity incentive plan was launched, the growth momentum is strong, and the “buy” rating is maintained.

02-27 09:57

McLander (688273.SH): Proposes to grant 3.3 million restricted shares to incentive recipients

Glonghui, Feb. 26 | McLander (688273.SH) announced the 2023 restricted stock incentive plan. The company plans to grant a total of 3.3 million shares to incentive targets, accounting for about 3.30% of the company's total share capital when this draft incentive plan was announced. Among them, the total number of restricted shares granted in the first category was 620 million shares, accounting for 0.62% of the company's total share capital when the draft incentive plan was announced and 18.79% of the total number of benefits to be granted under this incentive plan; the number of first-class restricted shares granted for the first time was 2,545 million shares, accounting for 2.55 of the company's total share capital at the time the draft incentive plan was announced

02-26 17:05

Mailand (688273.SH)'s net profit for 2022 was $123 million, up 3.93% year on year

According to the Zhitong Finance App, Mailand (688273.SH) released its 2022 annual performance report. During the reporting period, the company's total revenue was 377 million yuan, up 10.28% year on year; operating profit was 149 million yuan, up 14.44% year on year; total profit was 149 million yuan, up 14.71% year on year; net profit attributable to parent company owners was 123 million yuan, up 3.93% year on year. Net profit attributable to parent company owners after deducting non-recurring profit and loss was 89.259 million yuan, down 14.70% year on year. The main reason for the increase in the company's performance during the reporting period, 1

02-26 16:30

McLander (688273.SH) plans to introduce a restricted stock incentive plan for 2023, with a grant price of 21.16 yuan/share

According to the Zhitong Finance App, Mailand (688273.SH) released the 2023 Restricted Stock Incentive Plan (draft). This incentive plan intends to grant a total of 3.3 million shares to incentive targets, accounting for about 3.30% of the company's total share capital of 100 million shares when the draft incentive plan was announced. Among them, the total number of restricted shares granted in the first category was 620 million shares, accounting for 0.62% of the company's total share capital when the draft incentive plan was announced, accounting for 18.79% of the total number of rights to be granted under this incentive plan; the first number of restricted shares granted in the second category was 2,545 million shares, accounting for the time the draft incentive plan was announced

02-26 16:15

Mailand (688273): The launch of an equity incentive plan is optimistic about the company's long-term development

Incident: On February 26, 2023, the company disclosed its 2022 earnings report. The company's total revenue in 2022 was 376.7514 million yuan, up 10.28% year on year; operating profit was 14,8779 million yuan, up 14.44% year on year; total profit was 14,881884 million yuan, up 14.71% year on year; net profit attributable to parent company owners was 123,0372 million yuan, up 3.93% year on year; net profit attributable to parent company owners after deducting non-recurring profit and loss was 89.2509 million yuan, a year-on-year decline

02-26 00:00 · Researches